Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes

Interventions

BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

sargramostim

DRUG

busulfan

DRUG

etoposide

DRUG

fludarabine phosphate

DRUG

prednisone

DRUG

tacrolimus

PROCEDURE

allogeneic hematopoietic stem cell transplantation

PROCEDURE

umbilical cord blood transplantation

Trial Locations (1)

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00304018 - Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer | Biotech Hunter | Biotech Hunter